EDGAR Filing Documents for 0001415889-18-000080

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-18-000080

Filing Date

2018-01-18

Accepted

2018-01-18 20:00:16

Documents

Period of Report

2018-01-08

Document Format Files

Seq	Description	Document	Type	Size
1		form4-01182018_080102.html	4
1		form4-01182018_080102.xml	4	4235
	Complete submission text file	0001415889-18-000080.txt		5744

Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121

Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405

MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MABVAX THERAPEUTICS HOLDINGS, INC. 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121

Business Address

Type: 4 | Act: 34 | File No.: 001-37861 | Film No.: 18535211